Musings from the Future of the Microbiome – Winter 2021 Summit

January 6, 2022

We’re excited about the prospects for the microbiome to dramatically alter how we think about and approach health and wellness on both a personal and population basis in the near and mid-term future. Our team here at Trust Transparency Center therefore decided to double down on our coverage and exploration into this emerging area by hosting the Winter Edition of the Future of the Microbiome Summit December 7-9, 2021. You can register for the On Demand here if you missed the live event.

For those that have become used to my musings and takeaways at industry events and conferences, here goes:

We’ll start with a quick recap.

Day 1 started with a couple of presentations involving emerging prebiotic strategies and an examination of fermentation dynamics and metabolic pathways with an intention of investigating, predicting, and designing smart or ‘precision’ prebiotics. This session really struck home, because of our recent Global Prebiotic Association intense discussion of the applicability (or not) of the term ‘selective’ in the ISAPP definition of a prebiotic–our decision as GPA was to eliminate that word, at least currently, from the definition. It seems that a keen area the science is taking us is into is that precision rather than broad-spectrum space, and that perhaps there is a time in the not-too-distant future where we can sub-classify, precision and non, terming the former next generation. In fact, that theme of targeting and precision was probably a dominant one for the three days, even giving rise to a robust discussion around the implications of precision for personalization and for formulating with smaller yet highly efficacious doses. Along the way on day 1 we also talked about the possible benefits of preparing and presenting a fermentability index as a tool for research and product development.

Also on day 1, we discussed the impact of a plant-based and meat alternative diet on the microbiome, again discussing fermentation impact (watch that space as flexitarian rather than meat forward diets proliferate). From the Weizmann Institute in Israel, Eran Segal, a global expert in computational and quantitative biology discussed new work he is doing with implications for personalization, diabetes care, and atopic dermatitis. We also had a presentation that took us into the lung and other microbiota (again, watch that space), and finished the day discussing the connection between science and messaging, including appropriate and credible scientific rigor.

Day 2 began with a presentation about psychobiotics and the gut-brain axis, followed by a few presentations on measuring the microbiome, from pre-clinical all the way to commercial applications. Again, the dominant and consistent theme emerging was precision-otics. Commercial challenges discussed included the cost of testing and the need for longitudinal models and programs. Day 2 concluded with two deep presentations – one of which examined novel technology that included the use of blood-based markers as predictors of health condition with specific implications for public health policy and testing. The concluding presentation that day was on confounders in microbiota research and triggered a robust discussion on the practicality and responsibility to incorporate a structured examination of confounders as a research inclusion. While this presentation was specific to the microbiota, it well illustrated the challenges of over or under-interpreting research, especially in the case of meta-analyses where there might be different confounders.

The first two days set the stage well for Day 3 which included consumer insights from a variety of geographies showing the overall awareness of probiotics, prebiotics, synbiotics, and even postbiotics – results that were then challenged when survey respondents were asked to pick out the correct definition of each, with a gradual trailing off from probiotics to prebiotics to synbiotics and then postbiotics. These results confirm that for all, consumers are not exactly where we think they are and much more education is needed. One confirmation that did stand out was that the association with all of these categories goes much deeper than gut health and digestion and even immunity.

The day progressed into an examination of the potential misuse or misrepresentation of scientific and survey data – in research but especially beyond as it is picked up by the media with often distorted coverage. Again, this finding goes much broader than microbiome-related research, but in that complicated space, the potential for misuse is significant. Following up, the day discussed the importance again of microbiome-related products to other health states and implications for global health outcomes before finishing up with a session on consumer messaging with case studies.

Overall, the 3 days successfully presented topics that mixed science, health policy, and product development, touching on diagnostics, personalization and broader research implications.

My major take-aways:

  • Precision, precision, precision, especially in the world of prebiotics
  • We may finally be on track towards effective, viable, cost-effective approaches to personalization
  • Are we reaching the stage where we have too many ‘otics’ after ‘post’ and even ‘psycho’?
  • Messaging in the future will need to at least consider the concept of a ‘healthy microbiota’
  • Especially in nutrition science where lifestyle and other demographic and psychographic variables can impact outcomes, we need to deeply investigate potential confounders
  • Public health and health policy is yet another way where the microbiome as a vehicle/platform/tool can impact the future of human health

The sessions are all available On Demand here and stay tuned for more Future of the Microbiome programming through 2022.

~Len

richard151
Author: richard151

Unlock the Power of Transparency: Schedule a Meeting Now

Ready to Illuminate Your Path?
Partner with Trust Transparency Today.

Get inTouch

Lori Diez

Lori Diez combines compassion and excellence to lead organizations to their next level. A small-town Texas childhood taught her the value of hard work and relationships, which she uses to foster teamwork that brings results that have transformed cultures and programs to their highest potential. Her successful career in pharmaceutical and nutraceutical sales leadership and event hosting has prepared her to deliver results as the COO of TrustTransparency, where she uses her industry knowledge to ensure that the company’s operations run smoothly as they support nutraceutical companies in their mission to help others. Lori’s passion for charity reflects her belief that individuals working together can change the world, no matter how small their contribution to the effort. This year, she looks forward to continuing over a decade of service at the Houston Livestock Show And Rodeo, where she will be the Chairman of the Livestock Committee.

Conference Handouts

Conference Handouts

CoQ10 Statin Associated Myaglia Meta Study Barry Tan 0618 Case Study

CoQ10 Statin Associated Myaglia Meta Study Barry Tan 0618 (1)

Statin Q10 Effect Case Study

Statin Q10 Effect Case Study

Schedule Consultation with Trust Transparency

Glynnda Steinford

Glynnda Steinford, Trust Transparency Consulting’s Director of Customer Relations, brings over four decades of healthcare experience to her vital role in client engagement and relationship building. Her diverse background spans from administering medical groups to impactful stints in pharmaceutical and nutraceutical sales, all underlined by her degree in Healthcare Administration.

At the heart of Glynnda’s work is her talent for nurturing long-term connections, a skill she leverages to enhance client experiences and partnerships within the consultancy. Beyond her professional commitments, she enjoys life’s simple pleasures, whether it’s her love for cats and cooking or her ventures into golf, always prioritizing cherished moments with family and friends. Her personal interests echo the dedication and warmth she extends in her professional network, making her an invaluable asset to the team.

Caiti Dowden

Caiti Dowden stands as a crucial pillar at Trust Transparency Consulting, bringing invaluable insight and expertise to her role as Senior Executive Assistant’ since her start in 2018. With an academic background from Sam Houston University and a career shift from education to the nutraceutical sphere in 2010, Caiti has cultivated a sharp acumen for dissecting industry trends and bolstering strategic decision-making.

Her transition from Data Analyst reflects her growth and deep understanding of the business landscape. Caiti’s commitment goes beyond professional excellence; she thrives on balance, drawing from her rich life outside of work to enhance her organizational contributions. Whether it’s family time, volunteering, or rooting for Houston’s sports teams, she believes in embracing experiences to fuel her professional creativity and insight.

In her current role, Caiti’s dedication to dynamic business analysis and operational support proves her to be an irreplaceable asset to our team, embodying the synergy of personal enrichment and professional success.

Pam Hilpert

Pam Hilpert, Chief of Staff at Trust Transparency Consulting, has been instrumental in the firm since its inception, leveraging her 17 years of accounting experience, including a significant tenure in the nutrition sector. Her collaboration with Scott Steinford spans various successful ventures, emphasizing her integral role in the company’s financial and strategic initiatives.

An alumnus of Sam Houston State University, Pam holds degrees in both Business Administration and Accounting, as well as an MBA, adding academic heft to her practical industry insights. Beyond her professional prowess, Pam is passionate about family, enjoys live music, delves into quilting, and volunteers at her church, reflecting her well-rounded life.

Her multifaceted expertise and longstanding dedication make Pam a cornerstone of Trust Transparency Consulting’s operational strength and team unity.

Scott Steinford

Scott Steinford, a trailblazer in strategic leadership, boasts a certified M&A background, having navigated companies from their genesis to industry prominence. His brainchild, Trust Transparency Consulting, born in 2007, stands as a testament to his dedication to ethical business practices and strategic foresight, offering industry stakeholders invaluable guidance.

Beyond founding and steering companies, Scott has enriched the business landscape with his insightful keynotes and prolific written contributions, emphasizing his commitment to elevating industry standards. His executive tenure shines in roles as CEO or President of for-profits like ZMC-USA and Doctor’s Best, extending to significant contributions in non-profit sectors.

Notably, Scott’s influence is a driving force in the CoQ10 market, where his leadership has significantly bolstered the ingredient’s global presence. His roles in various capacities, including as a New Hope Ambassador, keep the community informed, providing in-depth industry reports and insights.

An active advocate within professional associations and an Editorial Advisor for leading industry publications, Scott’s expertise is both recognized and sought after. With academic roots in Pre-Law and a Master’s in Law, his journey transcends textbooks, embodying real-world business acumen and transformative leadership.

Scott Steinford merges visionary entrepreneurship with principled leadership, creating a legacy of innovation, growth, and unwavering commitment to industry excellence.